Revolution Medicines’ $230 Million Shares Offering

Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering.Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten public…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now